Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-09-25

FDA Approved: FLUVASTATIN — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for Fluvastatin (generic) under the ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluvastatin (fluvastatin)

Snippet

SUPPL AP for FLUVASTATIN (FLUVASTATIN)